EVERYTHING XIAOMI
Get listed
Side by side

Covidence vs LASER AI

Covidence

6.4#13 in systematic review softwareFrom $339 a year
Web
Visit

LASER AI

7.6#2 in ai literature review softwareFrom $3,000 a year
AndroidiOSWeb
Visit

What both publish

FactCovidenceLASER AI
FoundedCovidence states that it launched in 2014.Evidence Prime says it was founded in collaboration with McMaster University in 2014.
IntegrationsCovidence lists CRS, EndNote, Zotero, RefWorks, Mendeley, RevMan, and tools supporting RIS, CSV, or PubMedXML formats as compatible workflow tools.GetApp lists third-party integrations as a supported feature and rates that feature 5.0 from one review.
PurposeCovidence is a non-profit platform that helps researchers systematically review research.LASER AI is an AI-supported platform for accelerating literature reviews and evidence synthesis.
ScreeningReviewers can independently screen with blinding and structured conflict resolution, and record full-text exclusion reasons.It ranks records by estimated likelihood of meeting inclusion criteria and offers a customizable focus mode.
SecurityCovidence says it uses industry-standard encryption to store and transfer personal data and operates as a cloud-based service where data may be stored outside a user's country.The maker says LASER AI has FedRAMP LI-SaaS, SOC 2, and ISO 27001 certifications.
SupportThe contact page says the support team usually replies within one business day; pricing also includes free online technical support.GetApp lists email/help desk, phone support, knowledge base and FAQ/forum support, plus live online, webinar, documentation and video training.

Covidence plans

  • Single$339 a year
  • Package$907 a year
  • InstitutionsPriced on request

LASER AI plans

  • Per project$3,000, paid once
  • Per user$3,000 a year
  • EnterprisePriced on request

Pick Covidence if…

You want what its maker publishes above — check its page for the details.

Pick LASER AI if…

You want what its maker publishes above — check its page for the details.

Charts they share